Lymphocyte homeostasis following therapeutic lymphocyte depletion in multiple sclerosis.
Following lymphocyte depletion, homeostatic mechanisms drive the reconstitution of lymphocytes. We prospectively studied this process in 16 patients for 1 year after a single pulse of treatment with Campath-1H, a humanised anti-CD52 monoclonal antibody. We observed two phases of lymphocyte reconstit...
Main Authors: | Cox, A, Thompson, SA, Jones, J, Robertson, V, Hale, G, Waldmann, H, Compston, D, Coles, A |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2005
|
Similar Items
-
Preliminary evidence from magnetic resonance imaging for reduction in disease activity after lymphocyte depletion in multiple sclerosis.
by: Moreau, T, et al.
Published: (1994) -
The window of therapeutic opportunity in multiple sclerosis: evidence from monoclonal antibody therapy.
by: Coles, A, et al.
Published: (2006) -
Monoclonal antibodies for the depletion of specific subpopulations of lymphocytes.
by: Waldmann, H, et al.
Published: (1987) -
Transient increase in symptoms associated with cytokine release in patients with multiple sclerosis.
by: Moreau, T, et al.
Published: (1996) -
Elimination of graft-versus-host disease by in-vitro depletion of alloreactive lymphocytes with a monoclonal rat anti-human lymphocyte antibody (CAMPATH-1).
by: Waldmann, H, et al.
Published: (1984)